These effects, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two aid the thought of targeting ACKR3 as a novel solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-similar Diseases. Disclaimer: The above mentioned is https://danielf614oru4.dm-blog.com/profile